Denosumab effect on bone mineral density and urinary-NTX in breast cancer patients receiving aromatase inhibitors

ConclusionDenosumab increased BMD in patients treated with aromatase inhibitors. The u-NTX level decreased soon after start of denosumab treatment, and its change ratio is predictive of improvement in BMD.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research